BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1656313)

  • 1. Differential expression of insulin-like growth factor II in human meningiomas.
    Lichtor T; Kurpakus MA; Gurney ME
    Neurosurgery; 1991 Sep; 29(3):405-9; discussion 409-10. PubMed ID: 1656313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry.
    Antoniades HN; Galanopoulos T; Neville-Golden J; Maxwell M
    Int J Cancer; 1992 Jan; 50(2):215-22. PubMed ID: 1370435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of insulin-like growth factor II in human intracranial meningioma.
    Hultberg BM; Haselbacher G; Nielsen FC; Wulff BS; Gammeltoft S
    Cancer; 1993 Dec; 72(11):3282-6. PubMed ID: 8242555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of insulin-like growth factor (IGF) and glucose transporter-1 and -3 mRNA in CNS tumors.
    Glick RP; Unterman TG; Lacson R
    Regul Pept; 1993 Oct; 48(1-2):251-6. PubMed ID: 8265814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice.
    McCutcheon IE; Flyvbjerg A; Hill H; Li J; Bennett WF; Scarlett JA; Friend KE
    J Neurosurg; 2001 Mar; 94(3):487-92. PubMed ID: 11235955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas.
    Donnini S; Machein MR; Plate KH; Weich HA
    J Pathol; 1999 Sep; 189(1):66-71. PubMed ID: 10451490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone receptor expression in meningiomas.
    Carroll RS; Glowacka D; Dashner K; Black PM
    Cancer Res; 1993 Mar; 53(6):1312-6. PubMed ID: 8443810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma.
    Arrieta O; Garcia E; Guevara P; Garcia-Navarrete R; Ondarza R; Rembao D; Sotelo J
    Cancer; 2002 Jun; 94(12):3210-8. PubMed ID: 12115353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Exceptionally high content of mRNA of IGF-II-associated protein in meningiomas].
    Dmytrenko VV; Bukreieva TV; Shostak KO; Vitak NIa; Pekars'kyĭ IuA; Malysheva TA; Shamaiev MI; Rozumenko VD; Kondratiuk VV; Zozulia IuP; Kavsan VM
    Ukr Biokhim Zh (1999); 2007; 79(2):55-61. PubMed ID: 18030751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high ratio of insulin-like growth factor II/insulin-like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas.
    Nordqvist AC; Peyrard M; Pettersson H; Mathiesen T; Collins VP; Dumanski JP; Schalling M
    Cancer Res; 1997 Jul; 57(13):2611-4. PubMed ID: 9205065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
    Puri S; Joshi BH; Sarkar C; Mahapatra AK; Hussain E; Sinha S
    Cancer; 2005 May; 103(10):2132-42. PubMed ID: 15830341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurine concentration in human gliomas and meningiomas: tumoral, peritumoral, and extratumoral tissue.
    Cubillos S; Obregón F; Vargas MF; Salazar LA; Lima L
    Adv Exp Med Biol; 2006; 583():419-22. PubMed ID: 17153628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors.
    Boulle N; Logié A; Gicquel C; Perin L; Le Bouc Y
    J Clin Endocrinol Metab; 1998 May; 83(5):1713-20. PubMed ID: 9589681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas.
    Jensen RL; Soleau S; Bhayani MK; Christiansen D
    J Neurosurg; 2002 Sep; 97(3):658-67. PubMed ID: 12296651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue lipid composition of human gliomas and meningiomas.
    Kökoğlu E; Görseval A; Sönmez H; Ozyurt E
    Cancer Lett; 1992 Aug; 65(2):169-71. PubMed ID: 1511422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries.
    el-Roeiy A; Chen X; Roberts VJ; Shimasakai S; Ling N; LeRoith D; Roberts CT; Yen SS
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1488-96. PubMed ID: 7515389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
    J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of epidermal growth factor receptor in human meningiomas and meningeal tissue.
    Torp SH; Helseth E; Dalen A; Unsgaard G
    APMIS; 1992 Sep; 100(9):797-802. PubMed ID: 1389099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin and sialic acid levels in human meningiomas and gliomas.
    Sönmez H; Kökoğlu E; Süer S; Ozyurt E
    Cancer Lett; 1995 Apr; 90(2):119-22. PubMed ID: 7736446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and insulin-like growth factor I in brain tumors: binding and in vitro effects.
    Glick RP; Gettleman R; Patel K; Lakshman R; Tsibris JC
    Neurosurgery; 1989 Jun; 24(6):791-7. PubMed ID: 2546092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.